Lucio Lo Coco

Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study

Mariasanta Napolitano, Giorgia Saccullo, Alessandra Malato et al. · Journal of Clinical Oncology · 2014 · 107 citations · Full text

Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients

S. Siragusa, C Arcara, Alessandra Malato et al. · Annals of Oncology · 2005 · 101 citations

Pulmonary Embolism, Thrombosis, Venous Thrombosis +12

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study

Sergio Siragusa, Alessandra Malato, Giorgia Saccullo et al. · American Journal of Hematology · 2011 · 65 citations · Full text

Pharmacotherapy, Extended Dacus Study, Vitamin K Antagonist +18

Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM

Giuseppe Coppola, Egle Corrado, Ida Maria Muratori et al. · International Journal of Cardiology · 2005 · 54 citations

Inflammation, Thrombosis, Vascular Disease +14

Patients requiring interruption of long‐term oral anticoagulant therapy: the use of fixed sub‐therapeutic doses of low‐molecular‐weight heparin

Alessandra Malato, Giorgia Saccullo, Lucio Lo Coco et al. · Journal of Thrombosis and Haemostasis · 2009 · 45 citations

Thrombosis, Fixed Sub‐therapeutic Doses, Hematology +8